Citation only
via OpenAlex
A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels
Fahimeh Varzideh, Pasquale Mone, Gaetano Santulli
European Journal of Preventive Cardiology · 2026
Abstract
This editorial refers to ‘Accelerated ageing predicts earlier onset of ischaemic stroke: a proteomic and transcriptomic investigation’, by A. Qeck et al., https://doi.org/10.1093/eurjpc/zwaf691. For more than a decade, the field of vascular neurology has been tracking a worrying epidemiological trend: the incidence of ischaemic stroke among younger adults is rising in many regions, a pattern that cannot be fully explained by traditional risk factors alone. Multiple population-based studies and reviews have documented increasing stroke rates in adults under 50, suggesting that new or previously underappreciated mechanisms are contributing to earlier cerebrovascular vulnerability.1,2 Research on molecular measures of ageing, especially epigenetic clocks based on DNA methylation, has demonstrated relationships with cardiovascular outcomes, mortality, and subclinical atherosclerosis, implying that deviations between biological and chronological age could reflect cumulative physiological burden relevant to vascular disease.3 Proteomic approaches to measuring biological age were emerging rapidly; large-scale projects had begun to show that high-dimensional plasma protein signatures can predict mortality and multimorbidity and can be distilled into ageing clocks with substantial predictive power across diverse populations.4 Despite these advances, the explicit application of proteomic or transcriptomic ageing metrics to explain early-onset ischaemic stroke remained limited, and mechanistic links, particularly the possibility that unusual receptor systems or senescence(definition)-related pathways might drive vascular ageing, were only beginning to be explored within cardiovascular research.5 In the current issue of the European Journal of Preventive Cardiology, Quek et al.6 therefore entered fertile intellectual ground with a study that sought to translate the conceptual promise of biological ageing into a specific clinical problem: early-onset ischaemic stroke. By using a high-coverage proteomic platform and rigorous machine learning to build a proteomic ageing clock, they aligned with recent work4 showing that large-scale proteomic clocks can achieve high accuracy and predictive validity for age-related outcomes. The logic behind focusing on proteins is sound: proteins are proximal effectors of cellular function, inflammation, and vascular remodelling, processes central to stroke pathophysiology, and proteomic signatures may therefore capture dynamic aspects of biological ageing that other modalities (such as DNA methylation) reflect more indirectly. The field had already recognized epigenetic age acceleration as a biomarker linked to cardiovascular risk and subclinical atherosclerosis, so extending this paradigm to proteomics was a timely and rational next step.3 The principal empirical contributions are striking and merit careful reflection. First, the authors show that a substantial fraction of patients with acute ischaemic stroke (nearly 40% in their cohort) exhibit evidence of accelerated proteomic ageing compared with an age- and sex-stratified healthy reference sample. This high prevalence positions accelerated biological ageing as a common feature in the stroke population rather than a niche observation. Second, the magnitude of the association between accelerated age and stroke timing is clinically meaningful: accelerated agers experienced strokes on average nearly 9 years earlier than their non-accelerated peers. The effect persisted after adjustment for conventional vascular risk factors, suggesting that proteomic age captures risk dimensions not measured by standard clinical covariates. The paper further demonstrates that in younger patients (those under 50), the relation is particularly pronounced, with each additional year of proteomic-age excess increasing the odds of stroke by around 13%. These findings provide a plausible molecular explanation for part of the documented rise in early-onset stroke and suggest that ageing biology may partly account for cases that are cryptogenic by conventional assessment.6 Beyond cross-sectional associations, the longitudinal data in the study raise provocative questions about the bidirectional interplay between stroke and ageing. In a subset of patients rescanned 3 months after the index event, mean proteomic age increased by ∼2 years. Although this observation could reflect transient post-stroke inflammatory perturbations, it also raises an unsettling possibility: acute cerebrovascular injury might accelerate systemic molecular ageing, amplifying long-term vulnerability to recurrent events, cognitive decline, or frailty. This idea aligns with broader research on how acute insults can produce persistent physiologic shifts and with literature indicating that cellular senescence and the senescence-associated secretory phenotype contribute to cardiovascular pathology.7 Interrogating whether the post-stroke increase in biological age is durable, reversible, or predictive of long-term outcomes is an urgent priority for future longitudinal studies. The transcriptomic signals reported by Quek et al.6 add another novel layer. Their RNA-sequencing results identify enrichment of olfactory-signalling and sensory perception pathways in accelerated agers, an initially unexpected finding that gains plausibility when placed in the context of molecular biology work showing ectopic expression of olfactory receptors in vascular tissues and the heart. Experimental studies have demonstrated that certain olfactory receptors are expressed in the aorta and coronary endothelial cells and can modulate intracellular signalling pathways relevant to vasodilation, AKT signalling, and endothelial function. This ectopic receptor biology provides a mechanistic foothold for interpreting the transcriptomic enrichment observed in stroke patients with accelerated ageing. While the causal relevance of these pathways to stroke risk remains to be established, their identification broadens the
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/eurjpc/zwag023
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Varzideh, F., Mone, P., & Santulli, G. (2026). A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels. <em>European Journal of Preventive Cardiology</em>. https://doi.org/10.1093/eurjpc/zwag023
Vancouver
Varzideh F, Mone P, Santulli G. A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels. European Journal of Preventive Cardiology. 2026. doi:10.1093/eurjpc/zwag023.
BibTeX
@article{fahimeh2026Anewpr,
title = {A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels},
author = {Fahimeh Varzideh and Pasquale Mone and Gaetano Santulli},
journal = {European Journal of Preventive Cardiology},
year = {2026},
doi = {10.1093/eurjpc/zwag023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Epigenetics 2023
Open access · CC-BY
Epigenetic age acceleration in surviving versus deceased COVID-19 patients with acute respiratory distress syndrome following hospitalization
Nature Communications 2022
Open access · CC-BY
Accelerated biological aging in COVID-19 patients
Zenodo (CERN European Organization for Nuclear Research) 2023
Preprint · CC-BY
DNA Methylation Clock Analysis as a Biomarker of Biological Aging in Blood Cells
Aging 2016
Preprint · CC-BY
Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels
npj Aging 2026
Open access · CC-BY
How epigenetic clocks tick: unpacking the black box by deciphering biological pathways and transcriptomic signatures of accelerated aging
Frontiers in Aging Neuroscience 2022
Open access · CC-BY